Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials
<p><strong>Background</strong> Quinquennial overviews (1985–2000) of the randomised trials in early breast cancer have assessed the 5 year and 10-year effects of various systemic adjuvant therapies on breast cancer recurrence and survival. Here, we report the 10-year and 15-year ef...
Main Author: | Early Breast Cancer Trialists' Collaborative Group (EBCTCG) |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Elsevier
2005
|
Similar Items
-
Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials
by: Early Breast Cancer Trialists' Collaborative Group (EBCTCG)
Published: (2005) -
Adjuvant chemotherapy in oestrogen-receptor-poor breast cancer: patient-level meta-analysis of randomised trials
by: Early Breast Cancer Trialists' Collaborative Group (EBCTCG)
Published: (2008) -
Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trials
by: Early Breast Cancer Trialists' Collaborative Group (EBCTCG)
Published: (2011) -
Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials
by: Early Breast Cancer Trialists' Collaborative Group (EBCTCG)
Published: (2011) -
Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast
by: Early Breast Cancer Trialists’ Collaborative Group (EBCTCG)
Published: (2010)